Table 1. Efficacy and safety outcomes
| Ketoprofen in Transfersome | Topical placebo matching ketoprofen in Transfersome | |
|---|---|---|
| 100mg (n=274) | 100mg (n=281) | |
| WOMAC pain score | ||
| Baseline, median | 5.2 | 5.4 |
| Wk 12, median (mean Δ%) | 3.2 (–38.6) | 2.5 (–44.6) |
| WOMAC function score | ||
| Baseline, median | 5.4 | 5.5 |
| Wk 12, median (mean Δ%) | 3.3 (–37.4) | 2.8 (–42.3) |
| Patients’ global assessment of response to therapy at wk 12 (% patients) | ||
| “Good/excellent” | 54.7 | 60.5 |
| ≥1 AE (% patients) | 39.4 | 40.2 |